Patents by Inventor Stokes PEEBLES

Stokes PEEBLES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLP-1R agonists and uses thereof
    Patent number: 11666636
    Abstract: The present disclosure relates to glucagon-like peptide-1 receptor (GLP-1R) agonists and methods of treating or preventing allergic inflammation and/or methods of treating or preventing respiratory syncytial virus (RSV) infection.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: June 6, 2023
    Assignee: Vanderbilt University
    Inventors: Kevin Niswender, Stokes Peebles
  • PROSTACYCLIN, PROSTACYCLIN ANALOGS, AND METHODS OF TREATING OR PREVENTING REJECTION OF SOLID ORGAN TRANSPLANTS
    Publication number: 20200009105
    Abstract: The present disclosure relates to methods for treating or preventing rejection of solid organ transplants by administering prostacyclin (PGI2) or a prostacyclin analog.
    Type: Application
    Filed: February 28, 2018
    Publication date: January 9, 2020
    Applicants: Vanderbilt University, The United States as Represented by The Departmet of Veterans Affairs
    Inventor: Stokes PEEBLES
  • GLP-1R AGONISTS AND USES THEREOF
    Publication number: 20190358299
    Abstract: The present disclosure relates to glucagon-like peptide-1 receptor (GLP-1R) agonists and methods of treating or preventing allergic inflammation and/or methods of treating or preventing respiratory syncytial virus (RSV) infection.
    Type: Application
    Filed: February 14, 2018
    Publication date: November 28, 2019
    Inventors: Kevin NISWENDER, Stokes PEEBLES
  • Method of using prostacyclin to treat respiratory syncytial virus infections
    Patent number: 7132453
    Abstract: The present invention discloses methods and a kit for treating a respiratory syncytial virus infection. The method comprises providing an infection modulator, and administering a therapeutically effective amount of the infection modulator, wherein the respiratory syncytial virus infection is suppressed or precluded. The kit for suppressing a respiratory syncytial virus infection comprises an infection modulator, an applicator, and a set of instructions.
    Type: Grant
    Filed: March 14, 2003
    Date of Patent: November 7, 2006
    Assignee: Vanderbilt University
    Inventors: Ray Stokes Peebles, Jr., Koichi Hashimoto, Barney S. Graham
  • Method of using prostacyclin to treat respiratory syncytial virus infections
    Publication number: 20030216474
    Abstract: The present invention discloses methods and a kit for treating a respiratory syncytial virus infection. The method comprises providing an infection modulator, and administering a therapeutically effective amount of the infection modulator, wherein the respiratory syncytial virus infection is suppressed or precluded. The kit for suppressing a respiratory syncytial virus infection comprises an infection modulator, an applicator, and a set of instructions.
    Type: Application
    Filed: March 14, 2003
    Publication date: November 20, 2003
    Inventors: Ray Stokes Peebles, Koichi Hashimoto, Barney S. Graham